Your browser is no longer supported. Please, upgrade your browser.
Settings
OPK OPKO Health, Inc. daily Stock Chart
OPK [NASD]
OPKO Health, Inc.
Index- P/E- EPS (ttm)-0.48 Insider Own0.50% Shs Outstand640.58M Perf Week17.20%
Market Cap2.61B Forward P/E- EPS next Y-0.12 Insider Trans159.26% Shs Float403.19M Perf Month52.27%
Income-293.30M PEG- EPS next Q-0.08 Inst Own25.00% Short Float29.02% Perf Quarter189.21%
Sales890.90M P/S2.93 EPS this Y-94.60% Inst Trans-7.60% Short Ratio8.29 Perf Half Y171.62%
Book/sh2.42 P/B1.66 EPS next Y62.50% ROA-12.50% Target Price4.45 Perf Year78.67%
Cash/sh0.05 P/C75.62 EPS next 5Y12.00% ROE-18.00% 52W Range1.12 - 4.21 Perf YTD173.47%
Dividend- P/FCF- EPS past 5Y-5.40% ROI-14.90% 52W High-4.51% Beta2.29
Dividend %- Quick Ratio0.90 Sales past 5Y58.20% Gross Margin36.20% 52W Low259.86% ATR0.29
Employees6096 Current Ratio1.10 Sales Q/Q-4.90% Oper. Margin-26.90% RSI (14)78.34 Volatility8.94% 9.52%
OptionableYes Debt/Eq0.18 EPS Q/Q33.00% Profit Margin-32.90% Rel Volume1.21 Prev Close4.08
ShortableYes LT Debt/Eq0.17 EarningsMay 06 AMC Payout- Avg Volume14.12M Price4.02
Recom1.80 SMA2037.04% SMA5054.36% SMA200113.50% Volume17,058,605 Change-1.47%
Nov-25-19Initiated Piper Jaffray Overweight $2.50
Mar-02-18Downgrade JP Morgan Neutral → Underweight
Sep-14-17Downgrade JP Morgan Overweight → Neutral
Jun-21-16Reiterated Standpoint Research Buy $16 → $18
Jun-03-16Initiated Standpoint Research Buy $16
Mar-31-16Reiterated Barrington Research Outperform $17 → $16
Oct-16-15Initiated JP Morgan Overweight $14
Sep-11-15Downgrade Jefferies Buy → Hold
Mar-03-15Downgrade Oppenheimer Outperform → Perform
May-12-14Reiterated Oppenheimer Outperform $13 → $12
Mar-14-14Initiated Oppenheimer Outperform $13
Nov-13-13Reiterated Ladenburg Thalmann Buy $10 → $14.50
May-30-13Reiterated Ladenburg Thalmann Buy $8.50 → $10
Oct-22-12Initiated Barrington Research Outperform $6
Dec-01-11Reiterated Ladenburg Thalmann Buy $6 → $8.50
Jul-14-11Initiated Ladenburg Thalmann Buy $6
Jul-09-20 08:32AM  
08:00AM  
Jul-06-20 09:30AM  
Jul-03-20 11:30AM  
Jul-02-20 10:04AM  
Jul-01-20 08:15AM  
Jun-30-20 11:34PM  
Jun-29-20 06:48AM  
Jun-17-20 11:30AM  
Jun-16-20 08:40AM  
Jun-13-20 07:33AM  
Jun-09-20 08:00AM  
Jun-08-20 10:50AM  
Jun-05-20 11:31AM  
Jun-02-20 10:06AM  
09:42AM  
Jun-01-20 04:16PM  
12:00PM  
11:30AM  
11:02AM  
10:35AM  
08:00AM  
May-29-20 08:57AM  
May-28-20 08:50AM  
May-27-20 08:00AM  
May-20-20 08:40AM  
May-19-20 08:30AM  
08:02AM  
May-18-20 08:00AM  
May-15-20 09:31AM  
May-14-20 05:43PM  
May-13-20 04:05PM  
11:36AM  
08:30AM  
May-11-20 11:01AM  
10:16AM  
May-08-20 10:33AM  
09:00AM  
May-07-20 05:07PM  
07:00AM  
May-06-20 04:05PM  
May-04-20 10:59AM  
Apr-30-20 04:05PM  
Apr-29-20 01:35PM  
Apr-28-20 03:40PM  
12:33PM  
Apr-27-20 11:54AM  
Apr-22-20 08:00AM  
Apr-20-20 10:40AM  
Apr-16-20 12:02PM  
08:51AM  
Apr-15-20 08:55AM  
Apr-13-20 12:33PM  
Apr-12-20 06:57PM  
Apr-07-20 08:38AM  
Apr-06-20 12:09PM  
09:00AM  
Mar-30-20 11:28AM  
Mar-27-20 11:31AM  
Mar-25-20 08:00AM  
02:29AM  
Mar-24-20 02:30PM  
09:00AM  
08:43AM  
Mar-23-20 10:05AM  
07:00AM  
Mar-20-20 11:54AM  
Mar-17-20 02:26PM  
Mar-13-20 10:53AM  
08:13AM  
07:48AM  
07:43AM  
07:00AM  
Mar-11-20 10:15AM  
09:54AM  
05:28AM  
Mar-10-20 04:32PM  
Mar-09-20 09:36AM  
Mar-06-20 01:57PM  
09:25AM  
Mar-05-20 12:30PM  
07:23AM  
Feb-28-20 10:20AM  
Feb-27-20 09:47AM  
Feb-26-20 06:35PM  
04:05PM  
Feb-24-20 10:51AM  
Feb-20-20 12:15PM  
Feb-19-20 12:31PM  
Feb-08-20 09:11AM  
Feb-03-20 10:28AM  
08:46AM  
Jan-27-20 10:36AM  
Jan-20-20 11:02AM  
Jan-13-20 11:01AM  
Jan-06-20 10:40AM  
Dec-30-19 02:44PM  
Dec-27-19 10:04AM  
Dec-19-19 12:00PM  
08:00AM  
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase IIb trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc.; VARUBI for chemotherapy-induced nausea and vomiting; and Factor VIIa drug for hemophilia. In addition, this segment develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, it develops, manufactures, markets, and sells pharmaceutical, nutraceutical, and veterinary products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. Additionally, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FROST PHILLIP MD ET ALCEO & ChairmanJun 03Buy2.27100,000227,000190,221,694Jun 04 07:26 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 02Buy2.42100,000242,410190,121,694Jun 03 07:54 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 28Buy2.16100,000215,975190,021,694May 29 07:21 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 26Buy2.35250,000587,986189,921,694May 27 08:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 07Buy2.08400,000831,606189,671,694May 08 07:45 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 17Buy1.66325,000540,364189,271,694Apr 20 08:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 16Buy1.6325,00040,738188,946,694Apr 17 08:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 15Buy1.55200,000309,377188,921,694Apr 16 08:20 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 07Buy1.28400,000510,984188,721,694Apr 08 08:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 03Buy1.1550,00057,592188,321,694Apr 06 08:18 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 02Buy1.16500,000581,185188,271,694Apr 03 07:41 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 01Buy1.23643,549793,012187,771,694Apr 02 08:12 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 30Buy1.35161,968218,037187,128,145Mar 31 08:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 27Buy1.40100,000139,976186,966,177Mar 30 08:00 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 26Buy1.38200,000275,445186,866,177Mar 27 08:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 19Buy1.49100,000148,871186,666,177Mar 20 07:44 AM
Japour Anthony JDirectorMar 12Buy1.515007551,000Mar 13 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 10Buy1.61300,000481,636186,566,177Mar 11 09:45 AM
Japour Anthony JDirectorMar 03Buy1.47500735500Mar 04 01:51 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 03Buy1.47100,000147,000170,031,230Mar 04 06:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 02Buy1.49100,000148,978169,931,230Mar 03 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 28Buy1.46125,000182,099169,831,230Mar 02 06:47 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 27Buy1.48250,000369,816169,706,230Feb 28 06:07 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 14Buy1.57100,000157,291169,456,230Feb 18 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 13Buy1.58100,000158,000169,356,230Feb 14 06:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 11Buy1.5914,23922,640169,256,230Feb 12 06:07 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 06Buy1.5350,00076,500169,241,991Feb 07 07:20 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 31Buy1.4450,00071,750169,191,991Feb 03 06:53 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 30Buy1.47100,000147,000169,141,991Jan 31 07:23 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 24Buy1.5850,00079,000169,041,991Jan 27 06:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 23Buy1.6350,00081,500168,991,991Jan 24 07:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 17Buy1.5622,26234,729168,941,991Jan 21 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 13Buy1.4450,00072,000168,919,729Jan 14 06:07 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 10Buy1.4850,00074,000168,869,729Jan 13 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 08Buy1.4750,00073,500168,819,729Jan 09 06:53 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 30Buy1.46100,000146,000168,769,729Dec 31 08:14 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 27Buy1.53100,000152,500168,669,729Dec 30 07:44 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 19Buy1.48100,000148,229168,569,729Dec 20 06:18 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 18Buy1.50150,000224,750168,469,729Dec 19 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 17Buy1.5475,000115,375168,319,729Dec 18 06:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 11Buy1.50100,000150,172168,244,729Dec 12 06:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 09Buy1.5950,00079,500168,144,729Dec 10 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 05Buy1.6050,00080,000168,094,729Dec 06 06:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 03Buy1.6010,28616,458168,044,729Dec 04 06:38 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 02Buy1.5650,00077,755168,034,443Dec 03 07:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 26Buy1.55100,000154,500167,984,443Nov 27 06:45 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 19Buy1.47100,000146,651167,884,443Nov 20 06:55 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 18Buy1.48100,000147,925167,784,443Nov 19 06:22 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 13Buy1.4250,00071,191167,684,443Nov 14 07:08 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 12Buy1.44200,000288,124167,634,443Nov 13 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 08Buy1.4850,00074,058167,434,443Nov 12 06:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 06Buy1.49350,000520,503167,384,443Nov 07 06:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanOct 31Buy1.4350,00071,250167,034,443Nov 01 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanOct 30Buy1.44200,000288,533166,984,443Oct 31 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanOct 29Buy1.47200,000294,132166,784,443Oct 30 07:16 AM
PFENNIGER RICHARD C JRDirectorOct 25Buy1.4525,00036,243275,000Oct 25 04:11 PM
Rubin Steven DExecutive VP-AdministrationOct 25Buy1.5015,00022,5005,744,147Oct 25 02:46 PM
FROST PHILLIP MD ET ALCEO & ChairmanOct 25Buy1.502,000,0003,000,000166,234,443Oct 25 02:13 PM
HSIAO JANE PH DVice Chairman & CTOOct 25Buy1.50400,000600,0005,127,404Oct 25 02:10 PM
FROST PHILLIP MD ET ALCEO & ChairmanOct 25Buy1.40350,000491,121166,584,443Oct 28 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 16Buy2.1250,000105,98130,127,177Jul 17 07:14 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 12Buy2.1650,000107,78830,077,177Jul 15 06:55 AM